Sarizotan in Participants With Parkinson's Disease Suffering From Treatment Associated Dyskinesia
Status: | Completed |
---|---|
Conditions: | Parkinsons Disease |
Therapuetic Areas: | Neurology |
Healthy: | No |
Age Range: | 30 - Any |
Updated: | 4/17/2018 |
Start Date: | September 30, 2004 |
End Date: | March 31, 2006 |
A Double-Blind, Placebo-Controlled, Multicenter, Multinational Phase III Study to Evaluate the Safety and Efficacy of Sarizotan in Patients With Parkinson's Disease Suffering From Treatment-Associated Dyskinesia
The purpose of this study is to test multiple doses of sarizotan to establish a dose with
maximal safety and efficacy for treating treatment associated dyskinesia in Parkinson's
disease participants.
maximal safety and efficacy for treating treatment associated dyskinesia in Parkinson's
disease participants.
Inclusion Criteria:
- The participant is an out-patient
- The participant presents with a diagnosis of idiopathic Parkinson's disease
- Prior therapy with all registered Parkinsonian medication is allowed
Exclusion Criteria:
- (For female participants) The participant is pregnant or lactating
- The participant is participating in another clinical study or has done so within the
past 30 days
- The participant has received neurosurgical intervention related to Parkinson's disease
- The participant has relevant renal impairment
- The participant has relevant hepatic impairment
- The participant is suffering from any dementia or psychiatric illness
- The participant has a history of allergic asthma
We found this trial at
28
sites
Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials
